-+ 0.00%
-+ 0.00%
-+ 0.00%

DRUG MONITORING COMMITTEE AUTHORIZES CONTINUATION OF INTENSITY THERAPEUTICS' ONGOING GLOBAL RANDOMIZED PHASE 3 SARCOMA TRIAL ("INVINCIBLE-3 STUDY") FOLLOWING PERIODIC REVIEW

Reuters·01/28/2025 13:00:08

Please log in to view news